A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. - Wikidata - awgldk - TriplyDB

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

http://www.wikidata.org/entity/Q36887707

about

Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's Syndrome Decreased TSPAN1 promotes prostate cancer progression and is a marker for early biochemical recurrence after radical prostatectomy.Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications.Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.Genomic tests to guide prostate cancer management following diagnosis.Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.The context of prostate cancer genomics in personalized medicine.PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.Height, obesity, and the risk of TMPRSS2:ERG-defined prostate cancer.PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.Tissue-based biomarkers in prostate cancer.MSH2 Loss in Primary Prostate Cancer.A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases.Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature

P2860

Q30240027-24019646-CA29-40ED-BDFF-9AE186B17ED0 Q36407003-93C204C0-7289-4339-A97C-B791FBE09372 Q36965321-2E6C86DB-2DFA-416C-829F-12CD3745348C Q37616062-C8BC8487-01F5-4B03-85C2-E5C5803AC7C3 Q37665314-874B722A-C5F9-41F7-B93F-5C0F0441D455 Q38644658-DE66ACB4-3C76-43F0-A47C-202D0CB3EB4C Q38833458-277EB27E-D79F-4980-ADD8-A6F27948E6F4 Q38967389-9E8CD27A-F103-4C85-89D2-F98CD4AB3F42 Q39170943-AEAED40C-4882-4F13-A844-4A0C7A11935B Q39540003-B50FAA9D-8EC2-4472-A30E-E0DB039B5279 Q41839243-F683817B-D12D-4A0A-8A47-3E1352F59C17 Q41912121-4764104B-614C-4FDE-803B-A6CE3A15444F Q42363171-24ADE39E-E590-4C8A-A04C-65052E8E2716 Q42371556-98B1BB84-FD71-4B3D-B846-72DBA3D491BB Q43269413-8C663D72-AA95-4FA5-8A83-009D55042762 Q45944320-99A2D067-43C2-4CE1-87FA-5C6A31EC31CE Q46000712-54CC2ABF-CBF0-4ABE-A654-6A78E27A06F6 Q47144748-E20D74E4-A2C2-4391-8535-1912C1024A05 Q47976701-70B445B3-432C-4B43-A5D5-B6974D69A664 Q52318912-CE404BD5-A38D-4426-AC00-31A2841BDFB0 Q54474207-9ECEE96D-69A9-4073-9D28-C0FB3F40AD20 Q54977196-6F82836F-D0ED-4100-930C-EA88391B69B1 Q57073785-61409D8C-31B3-44B3-85E4-F13BC69B5302

P2860

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

http://www.wikidata.org/entity/Q36887707

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

@en

type

label

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

@en

prefLabel

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

@en

P1433

Q36887707-91CA9925-958D-4C54-8A6D-191D90C45FE9

P1476

Q36887707-CF08DC01-1D5E-47D3-9F0B-B5437F53EC69

P2093

Q36887707-0C23561B-99F0-42BB-94AE-4538B49F9ED8

Q36887707-665D16FF-1854-4088-94FF-EF50491220DD

Q36887707-6F220713-76F5-4B8B-B1D8-B6FDEA365E7F

Q36887707-840EBBAE-69B2-4080-B399-F6228BAF836B

Q36887707-93ABC701-7399-4462-8693-3DA909E6C123

Q36887707-9EDCB26E-22B3-406B-9ABE-3D5ADE786A9A

Q36887707-A2201EE4-5BF3-4D6C-874F-93FB849EF219

Q36887707-B3FA6932-BED6-4C70-BB80-7B82E8C9EC6E

Q36887707-B66CC42C-D2A3-49F5-8CCE-846FF11D70B6

Q36887707-F0AC28E0-CF0A-46B5-92B3-A42338CEC941

P2860

Q36887707-103FE10D-B030-4F09-88D8-52F8873DE6BE

Q36887707-1C883FB3-3C9D-4F6B-BBD0-2D53F3CBF6B2

Q36887707-205F8887-00ED-4824-A65C-3AD2F8CB0DC4

Q36887707-243A19AB-215F-4CE7-BDC2-7B3AA2B6EBC4

Q36887707-2CF9334C-7A1E-4B6C-B801-6FDE3BB4E2F7

Q36887707-2E4F9DA1-1C07-457F-8A97-5420BA07BD80

Q36887707-3641DE42-AD33-4814-A8D1-A0DD05289813

Q36887707-38B7FA74-C2A0-42D7-8043-A6864C1C6DAB

Q36887707-3B2EA430-0A62-438E-A62A-6003633F1F15

Q36887707-3C3F8019-6C85-4C21-88AF-72954A549D8B

P31

Q36887707-F112394D-9047-4FB3-96AD-325C79382AE8

P356

Q36887707-407D7633-E51F-4866-8107-F8EB357CA7B9

P407

Q36887707-C76B18AD-D1BC-41C9-A2A3-29465E457D7B

P433

Q36887707-282A1288-4B25-45DD-8645-EE6D677DBCA3

P478

Q36887707-B2F93880-C698-46EC-9C8E-C9ADD18348AC

P50

Q36887707-35F42F24-4794-43A6-977B-5FA5A813F25B

Q36887707-40400FCC-29D1-4C84-8337-358D8F059FB1

Q36887707-56F6CA65-A436-4F84-AEA7-3201F6373589

Q36887707-58737B53-2D0F-4520-A8BC-8CBE1606C778

Q36887707-5E749F94-632F-4793-A85E-50C48EE3CA46

Q36887707-697A8E9D-7FAA-41E5-919B-AC5361D9396F

Q36887707-845F7823-C961-4B0B-B7EF-40E1549EC091

Q36887707-9938ED29-5519-4C9C-AB15-B81FA658F5BE

P577

Q36887707-DA92F574-F956-4E0F-A048-3798A41E1246

P698

Q36887707-48B85F36-7868-470A-A3AD-B17D8FD8C243

P932

Q36887707-EDEADD57-24BB-4C01-A185-1C5852BFF941

P356

P1433

Journal of the National Cancer Institute

P1476

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.

@en

P2093

Andreas Pettersson

http://www.w3.org/2001/XMLSchema#string

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Carlos L Morais

http://www.w3.org/2001/XMLSchema#string

Ericka M Ebot

http://www.w3.org/2001/XMLSchema#string

Howard D Sesso

http://www.w3.org/2001/XMLSchema#string

Jessica L Hicks

http://www.w3.org/2001/XMLSchema#string

Kathryn M Wilson

http://www.w3.org/2001/XMLSchema#string

Michelangelo Fiorentino

http://www.w3.org/2001/XMLSchema#string

Rebecca E Graff

http://www.w3.org/2001/XMLSchema#string

Richard Flavin

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

The genomic complexity of primary human prostate cancer

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

The mutational landscape of lethal castration-resistant prostate cancer

Integrative genomic profiling of human prostate cancer

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.

P31

scholarly article

P356

10.1093/JNCI/DJV346

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Stephen P. Finn

Jennifer R Stark

Lorelei A Mucci

Meir J Stampfer

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26615022

http://www.w3.org/2001/XMLSchema#string

P932

4862436

http://www.w3.org/2001/XMLSchema#string